AbbVie Investor Aims To Skunk $54B Shire Inversion
By Jamie Santo · September 16, 2014, 10:03 PM EDT
An AbbVie Inc. shareholder launched a putative class action Monday aimed at stopping the U.S. drugmaker's planned $54 billion takeover of European rival Shire PLC, claiming the inversion deal designed to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login